Bridgebio Pharma Inc
(BBIO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 432,871 | 414,619 | 483,235 | 470,098 | 371,550 |
| Marketable Securities | 83,925 | 95,233 | 108,742 | 245,607 | 299,676 |
| Receivables | 10,761 | 17,079 | 24,581 | 22,821 | 10,983 |
| TOTAL | $552,702 | $548,853 | $642,219 | $771,280 | $716,230 |
| Non-Current Assets | |||||
| PPE Net | 13,566 | 14,569 | 15,603 | 16,873 | 17,182 |
| Intangibles | 28,113 | 28,712 | 29,310 | 29,908 | 30,476 |
| Other Non-Current Assets | 31,299 | 30,902 | 41,608 | 44,172 | 49,261 |
| TOTAL | $72,978 | $74,183 | $86,521 | $90,953 | $96,919 |
| Total Assets | $625,680 | $623,036 | $728,740 | $862,233 | $813,149 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,076 | 11,558 | 10,158 | 8,793 | 10,107 |
| Accrued Expenses | 59,948 | 98,039 | 73,636 | 88,883 | 64,211 |
| TOTAL | $96,596 | $121,428 | $119,194 | $141,160 | $103,463 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,713,292 | 1,707,615 | 1,698,693 | 1,693,179 | 1,708,050 |
| Deferred Revenues | 6,675 | 8,156 | 7,518 | 7,190 | N/A |
| Other Non-Current Liabilities | 31,777 | 40,307 | 41,692 | 34,111 | 47,592 |
| TOTAL | $1,742,493 | $1,744,943 | $1,737,531 | $1,734,587 | $1,750,709 |
| Total Liabilities | $1,839,089 | $1,866,371 | $1,856,725 | $1,875,747 | $1,854,172 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 160,501 | 151,373 | 149,483 | 148,246 | 147,694 |
| Common Shares | 167 | 157 | 156 | 154 | 154 |
| Retained earnings | -2,057,455 | -1,918,149 | -1,780,558 | -1,643,219 | -1,633,363 |
| Other shareholders' equity | 12,244 | 10,954 | 10,084 | 11,591 | -410 |
| TOTAL | $-1,213,409 | $-1,243,335 | $-1,127,985 | $-1,013,514 | $-1,041,023 |
| Total Liabilities And Equity | $625,680 | $623,036 | $728,740 | $862,233 | $813,149 |